Nucleic Acid-based Drugs Market Foreseen to Grow Exponentially by 2030

According to the Regional Research Reports, the global nucleic acid-based drugs market size was estimated to grow at a CAGR of 6.2% during the forecast period.

Nucleic acid therapeutics, based on nucleic acids or closely related chemical compounds, are an emerging new class of therapeutics for treating unmet medical needs. They are capable of targeting a disease at the genetic level by preventing the expression of disease-causing proteins. Nucleic acid drugs are being developed as novel therapeutic modalities. They have great potential to treat human diseases such as cancers, viral infections, and genetic disorders due to unique characteristics that make it possible to approach undruggable targets using classical small molecule or protein/antibody-based biologics.

Get Full PDF Sample Copy of Report Nucleic Acid-based Drugs [email protected] https://www.regionalresearchreports.com/request-sample/global-nucleic-acid-based-drugs-market/HP-1703 

Nucleic acid drugs control the biological functions of cells, based on nucleotide sequence information. The functioning of these drugs is either based on their expression in cells or is mediated through the regulation of genes, specifically those having complementary sequences. Recently, non-coding RNAs such as microRNAs (miRNAs), which are not translated into proteins, have been shown to be involved in several biological processes. Nucleic acid drugs can also be used to target such molecules. As of June 2021, 15 drugs were approved. The first nucleic acid drug was an ASO type approved in 1998, which was followed by the SSO type in 2016 and siRNA drugs in 2018, and mRNA drugs in 2020.

This report contains the market size and forecasts of Nucleic Acid-based Drugs in the global market, including the following market information:

  • Global Nucleic Acid-based Drugs Market Revenue, 2018-2021, 2022-2030, (US$ Millions)
  • Global top five Nucleic Acid-based Drugs companies in 2021 (%)

Regional Research Reports has surveyed the Nucleic Acid-based Drugs manufacturers, suppliers, distributors, and industry experts in this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nucleic Acid-based Drugs Market, By Type, 2018-2021, 2022-2030 (US$ Millions)

Global Nucleic Acid-based Drugs Market Segment Percentages, By Type, 2021 (%)

  • Anti-Sense And Anti-Gene
  • Short Inhibitory Sequences
  • Gene Transfer Therapy
  • Nucleoside Analogs
  • Ribozymes
  • Aptamers

Global Nucleic Acid-based Drugs Market, By Structure, 2018-2021, 2022-2030 (US$ Millions)

Global Nucleic Acid-based Drugs Market Segment Percentages, By Structure, 2021 (%)

  • Single Stranded DNA/RNA
  • Double Stranded DNA
  • Single-Stranded DNA
  • Others

Global Nucleic Acid-based Drugs Market, By Target, 2018-2021, 2022-2030 (US$ Millions)

Global Nucleic Acid-based Drugs Market Segment Percentages, By Target, 2021 (%)

  • Transcriptor Factor
  • TLR9-Receptor
  • Protein

Global Nucleic Acid-based Drugs Market, By End Users, 2018-2021, 2022-2030 (US$ Millions)

Global Nucleic Acid-based Drugs Market Segment Percentages, By End Users, 2021 (%)

  • Hospitals
  • Specialty Clinics
  • Others

Request For Report Discount @ https://www.regionalresearchreports.com/request-for-special-pricing/global-nucleic-acid-based-drugs-market/HP-1703 

Global Nucleic Acid-based Drugs Market, By Region and Country, 2018-2021, 2022-2030 (US$ Millions)

Global Nucleic Acid-based Drugs Market Segment Percentages, By Region and Country, 2021 (%)

  • North America (US, Canada, Mexico)
  • South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
  • Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
  • The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)  

Competitor Analysis of the Global Nucleic Acid-based Drugs Market

The report also provides an analysis of leading market participants, including:

  • Key companies Nucleic Acid-based Drugs revenues in global market, 2018-2021 (Estimated), (US$ Millions)
  • Key companies Nucleic Acid-based Drugs revenues share in global market, 2021 (%)
  • Key companies Nucleic Acid-based Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market; key players include:

  • Wave Life Sciences
  • Imugene
  • Caperna
  • Phylogica
  • Protagonist Therapeutics
  • Benitec Biopharma
  • EGEN
  • BioMedica
  • Transgene
  • Nubad LLC

Request For Report Description @ https://www.regionalresearchreports.com/industry-reports/global-nucleic-acid-based-drugs-market/HP-1703 

Regional Research Reports solves all the data problems by providing industry analytics data that is easy to understand and reliable. We are a leading provider of custom and exclusive market research reports; we provide state-of-the-art business analysis to clients across multiple sectors.

Our research team is highly qualified to benefit well-establish companies and startups with their market research needs. In a world where endless disruption is the norm, not the exception, Regional Research Reports provides the foundation for a strategy to identify opportunities and challenges early and win customers. Since our founding, we have been working closely with large multinationals and small and medium-sized enterprises (SMEs). Today, we are proud to have 80% of our Fortune 2000 customers as our customers.

Contact US:

Richard Watson

414 S Reed St, Lakewood,

Colorado, 80226, USA

USA:  +1 (844) 910-4477

Email: [email protected]

Web: https://www.regionalresearchreports.com

Leave a Reply

Your email address will not be published.